Free Trial

Brookdale Senior Living (BKD) Stock Forecast & Price Target

Brookdale Senior Living logo
$5.22 +0.02 (+0.38%)
(As of 11/20/2024 ET)

Brookdale Senior Living - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
0
Buy
3

Based on 4 Wall Street analysts who have issued ratings for Brookdale Senior Living in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 4 analysts, 1 has given a sell rating, and 3 have given a buy rating for BKD.

Consensus Price Target

$7.75
48.47% Upside
According to the 4 analysts' twelve-month price targets for Brookdale Senior Living, the average price target is $7.75. The highest price target for BKD is $9.00, while the lowest price target for BKD is $6.00. The average price target represents a forecasted upside of 48.47% from the current price of $5.22.
Get the Latest News and Ratings for BKD and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Brookdale Senior Living and its competitors.

Sign Up

BKD Analyst Ratings Over Time

TypeCurrent Forecast
11/22/23 to 11/21/24
1 Month Ago
10/23/23 to 10/22/24
3 Months Ago
8/24/23 to 8/23/24
1 Year Ago
11/22/22 to 11/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
2 Buy rating(s)
1 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$7.75$7.75$7.50$6.50
Forecasted Upside48.47% Upside25.40% Upside4.75% Upside24.16% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

BKD Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BKD Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Brookdale Senior Living Stock vs. The Competition

TypeBrookdale Senior LivingMedical CompaniesS&P 500
Consensus Rating Score
2.50
2.80
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside48.47% Upside26,906.43% Upside9.81% Upside
News Sentiment Rating
Neutral News

See Recent BKD News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/16/2024Jefferies Financial Group
2 of 5 stars
 Initiated CoverageBuy$8.00+31.80%
10/9/2024Macquarie
2 of 5 stars
 Reiterated RatingOutperform ➝ Outperform$8.00 ➝ $8.00+39.37%
10/9/2024Royal Bank of Canada
4 of 5 stars
 Reiterated RatingOutperform ➝ Outperform$9.00 ➝ $9.00+59.57%
10/7/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underperform$7.75 ➝ $6.00-3.23%
1/17/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$5.00 ➝ $4.00+46.52%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 06:46 AM ET.


BKD Forecast - Frequently Asked Questions

According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Brookdale Senior Living is $7.75, with a high forecast of $9.00 and a low forecast of $6.00.

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Brookdale Senior Living in the last twelve months. There is currently 1 sell rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" BKD shares.

According to analysts, Brookdale Senior Living's stock has a predicted upside of 48.47% based on their 12-month stock forecasts.

Over the previous 90 days, Brookdale Senior Living's stock had 1 downgrade by analysts.

Brookdale Senior Living has been rated by research analysts at Bank of America, Jefferies Financial Group, Macquarie, and Royal Bank of Canada in the past 90 days.

Analysts like Brookdale Senior Living less than other "medical" companies. The consensus rating score for Brookdale Senior Living is 2.50 while the average consensus rating score for "medical" companies is 2.80. Learn more on how BKD compares to other companies.


This page (NYSE:BKD) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners